Ipamorelin Consent Form Template
$599
Ipamorelin is an investigational synthetic peptide and selective growth hormone secretagogue that stimulates the pituitary gland to release growth hormone in a natural, pulsatile manner. Unlike broader growth hormone stimulants, Ipamorelin is valued for its targeted action — promoting growth hormone release without significantly affecting cortisol or prolactin levels, making it one of the more precise options in peptide therapy.
It is being explored for its potential to support lean muscle development, fat metabolism, recovery, sleep quality, and healthy aging — with growing interest in its favorable tolerability profile compared to other growth hormone-stimulating peptides.
Before beginning treatment, all patients complete a detailed informed consent process covering how Ipamorelin works, its experimental status, potential benefits, known side effects, contraindications, and patient responsibilities. As Ipamorelin is not FDA-approved, all use is considered investigational and is conducted under qualified medical supervision.
